A signature of maternal anti-fetal rejection in spontaneous preterm birth: Chronic chorioamnionitis, anti-human leukocyte antigen antibodies, and C4d

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Lee, JoonHo ^a,g   Romero, Roberto ^a,b   Xu, Yi ^a   Kim, Jung Sun ^c   Topping, Vanessa ^a   Yoo, Wonsuk ^b   Kusanovic, Juan Pedro ^a,d,e   Chaiworapongsa, Tinnakorn ^a,b   Hassan, Sonia S ^a,b   Yoon, Bo Hyun ^f   Kim, Chong Jai ^a,b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d HOSPITAL DR SÓTERO DEL RÍO   (Chile)

^e PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^f Seoul National University College of Medicine   (South Korea)

^g NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIBODY; HLA ANTIBODY; HLA ANTIBODY CLASS 1; HLA ANTIBODY CLASS 2; LEUKOCYTE ANTIBODY; UNCLASSIFIED DRUG; ANTIBODY; COMPLEMENT C4D; COMPLEMENT COMPONENT C4B; HLA ANTIGEN; PEPTIDE FRAGMENT;

ADULT; AGE DISTRIBUTION; ALLOIMMUNITY; ARTICLE; BIRTH WEIGHT; CASE REPORT; CELL INFILTRATION; CESAREAN SECTION; CHORIOAMNIONITIS; CHRONIC DISEASE; CONTROLLED STUDY; FEMALE; FETUS WASTAGE; FLOW CYTOMETRY; GESTATIONAL AGE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NEWBORN; NULLIPARA; OCCLUSIVE CEREBROVASCULAR DISEASE; PARITY; PREMATURE LABOR; PRIMIGRAVIDA; UMBILICAL VEIN ENDOTHELIAL CELL; BLOOD; CROSS-SECTIONAL STUDY; FETOMATERNAL TRANSFUSION; FETUS; GRAFT REJECTION; HISTOCOMPATIBILITY; IMMUNOLOGY; PHYSIOLOGY; PREGNANCY; PREMATURITY;

ADULT; ANTIBODIES; CHORIOAMNIONITIS; CHRONIC DISEASE; COMPLEMENT C4B; CROSS-SECTIONAL STUDIES; FEMALE; FETUS; GRAFT REJECTION; HISTOCOMPATIBILITY, MATERNAL-FETAL; HLA ANTIGENS; HUMANS; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; PEPTIDE FRAGMENTS; PREGNANCY; PREMATURE BIRTH;

EID: 79951519837     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016806     Document Type: Article

References (58)

1. Goldenberg RL, Culhane JF, Iams JD, Romero R, (2008) Epidemiology and causes of preterm birth. Lancet 371: 75-84.
2. Slattery MM, Morrison JJ, (2002) Preterm delivery. Lancet 360: 1489-1497.
3. Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, et al. (2007) Births: final data for 2005. Natl Vital Stat Rep 56: 1-103.
4. Raju TN, (2006) Epidemiology of late preterm (near-term) births. Clin Perinatol 33: 751-763.
5. Russell RB, Green NS, Steiner CA, Meikle S, Howse JL, et al. (2007) Cost of hospitalization for preterm and low birth weight infants in the United States. Pediatrics 120: e1-e9.
6. Romero R, Espinoza J, Kusanovic JP, Gotsch F, Hassan S, et al. (2006) The preterm parturition syndrome. BJOG 113 (Suppl 3): 17-42.
7. Guleria I, Sayegh MH, (2007) Maternal acceptance of the fetus: true human tolerance. J Immunol 178: 3345-3351.
8. von Rango U, (2008) Fetal tolerance in human pregnancy-a crucial balance between acceptance and limitation of trophoblast invasion. Immunol Lett 115: 21-32.
9. Redman CW, (1983) Immune factors and recurrent abortion: a review. Am J Reprod Immunol 4: 179-181.
10. Kilpatrick DC, (1987) Immune mechanisms and pre-eclampsia. Lancet 2: 1460-1461.
11. Aksel S, (1992) Immunologic aspects of reproductive diseases. JAMA 268: 2930-2934.
12. Le Moine A, Goldman M, Abramowicz D, (2002) Multiple pathways to allograft rejection. Transplantation 73: 1373-1381.
13. Kim IK, Bedi DS, Denecke C, Ge X, Tullius SG, (2008) Impact of innate and adaptive immunity on rejection and tolerance. Transplantation 86: 889-894.
14. Howell WM, Carter V, Clark B, (2010) The HLA system: immunobiology, HLA typing, antibody screening and crossmatching techniques. J Clin Pathol 63: 387-390.
15. Zeevi A, Girnita A, Duquesnoy R, (2006) HLA antibody analysis: sensitivity, specificity, and clinical significance in solid organ transplantation. Immunol Res 36: 255-264.
16. Rowshani AT, Bemelman FJ, Lardy NM, Ten Berge IJ, (2008) Humoral immunity in renal transplantation: clinical significance and therapeutic approach. Clin Transplant 22: 689-699.
17. Kim MJ, Romero R, Kim CJ, Tarca AL, Chhauy S, et al. (2009) Villitis of unknown etiology is associated with a distinct pattern of chemokine up-regulation in the feto-maternal and placental compartments: implications for conjoint maternal allograft rejection and maternal anti-fetal graft-versus-host disease. J Immunol 182: 3919-3927.
18. Kim CJ, Romero R, Kusanovic JP, Yoo W, Dong Z, et al. (2010) The frequency, clinical significance, and pathological features of chronic chorioamnionitis: a lesion associated with spontaneous preterm birth. Mod Pathol 23: 1000-1011.
19. Jacques SM, Qureshi F, (1998) Chronic chorioamnionitis: a clinicopathologic and immunohistochemical study. Hum Pathol 29: 1457-1461.
20. Redline RW, Patterson P, (1993) Villitis of unknown etiology is associated with major infiltration of fetal tissue by maternal inflammatory cells. Am J Pathol 143: 473-479.
21. Sargent IL, Wilkins T, Redman CW, (1988) Maternal immune responses to the fetus in early pregnancy and recurrent miscarriage. Lancet 2: 1099-1104.
22. Regan L, Braude PR, Hill DP, (1991) A prospective study of the incidence, time of appearance and significance of anti-paternal lymphocytotoxic antibodies in human pregnancy. Hum Reprod 6: 294-298.
23. Nielsen HS, Witvliet MD, Steffensen R, Haasnoot GW, Goulmy E, et al. (2010) The presence of HLA-antibodies in recurrent miscarriage patients is associated with a reduced chance of a live birth. J Reprod Immunol 87: 67-73.
24. Bartel G, Walch K, Wahrmann M, Pils S, Kussel L, et al. (2010) Prevalence and qualitative properties of circulating anti-human leukocyte antigen alloantibodies after pregnancy: No association with unexplained recurrent miscarriage. Hum Immunol DOI:10.1016/j.humimm.2010.11.005.
25. Agrawal S, Pandey MK, Mandal S, Mishra L, Agarwal S, (2002) Humoral immune response to an allogenic foetus in normal fertile women and recurrent aborters. BMC Pregnancy Childbirth 2: 6.
26. Pandey MK, Thakur S, Agrawal S, (2004) Lymphocyte immunotherapy and its probable mechanism in the maintenance of pregnancy in women with recurrent spontaneous abortion. Arch Gynecol Obstet 269: 161-172.
27. Porter TF, LaCoursiere Y, Scott JR, (2006) Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev CD000112.
28. Schild RL, Hoch J, Plath H, Geissen C, Fahnenstich H, et al. (1999) Perinatal management of fetal hemolytic disease due to Rh incompatibility combined with fetal alloimmune thrombocytopenia due to HPA-5b incompatibility. Ultrasound Obstet Gynecol 14: 64-67.
29. Saito S, Ota M, Komatsu Y, Ota S, Aoki S, et al. (2003) Serologic analysis of three cases of neonatal alloimmune thrombocytopenia associated with HLA antibodies. Transfusion 43: 908-917.
30. Redline RW, Heller D, Keating S, Kingdom J, (2005) Placental diagnostic criteria and clinical correlation-a workshop report. Placenta 26 (Suppl A): S114-S117.
31. Betkowski AS, Graff R, Chen JJ, Hauptman PJ, (2002) Panel-reactive antibody screening practices prior to heart transplantation. J Heart Lung Transplant 21: 644-650.
32. Bartel G, Wahrmann M, Exner M, Regele H, Schillinger M, et al. (2007) Determinants of the complement-fixing ability of recipient presensitization against HLA antigens. Transplantation 83: 727-733.
33. Simister NE, (2003) Placental transport of immunoglobulin G. Vaccine 21: 3365-3369.
34. Adeniyi-Jones SC, Ozato K, (1987) Transfer of antibodies directed to paternal major histocompatibility class I antigens from pregnant mice to the developing fetus. J Immunol 138: 1408-1415.
35. Moncharmont P, Dubois V, Obegi C, Vignal M, Merieux Y, et al. (2004) HLA antibodies and neonatal alloimmune thrombocytopenia. Acta Haematol 111: 215-220.
36. Thude H, Schorner U, Helfricht C, Loth M, Maak B, et al. (2006) Neonatal alloimmune thrombocytopenia caused by human leucocyte antigen-B27 antibody. Transfus Med 16: 143-149.
37. Althaus J, Weir EG, Askin F, Kickler TS, Blakemore K, (2005) Chronic villitis in untreated neonatal alloimmune thrombocytopenia: an etiology for severe early intrauterine growth restriction and the effect of intravenous immunoglobulin therapy. Am J Obstet Gynecol 193: 1100-1104.
38. Gu D, Chen Z, Zhao H, Du W, Xue F, et al. (2010) Th1 (CXCL10) and Th2 (CCL2) chemokine expression in patients with immune thrombocytopenia. Hum Immunol 71: 586-591.
39. Wasowska BA, (2010) Mechanisms involved in antibody- and complement-mediated allograft rejection. Immunol Res 47: 25-44.
40. Wilczynski JR, (2006) Immunological analogy between allograft rejection, recurrent abortion and pre-eclampsia- the same basic mechanism? Hum Immunol 67: 492-511.
41. Cohen F, Zuelzer WW, Gustafson DC, Evans MM, (1964) Mechanisms of isoimmunization. I. The transplacental passage of fetal erythrocytes in homospecific pregnancies. Blood 23: 621-646.
42. Sebring ES, Polesky HF, (1990) Fetomaternal hemorrhage: incidence, risk factors, time of occurrence, and clinical effects. Transfusion 30: 344-357.
43. Taglauer ES, Adams Waldorf KM, Petroff MG, (2010) The hidden maternal-fetal interface: events involving the lymphoid organs in maternal-fetal tolerance. Int J Dev Biol 54: 421-430.
44. Tilburgs T, Scherjon SA, Claas FH, (2010) Major histocompatibility complex (MHC)-mediated immune regulation of decidual leukocytes at the fetal-maternal interface. J Reprod Immunol 85: 58-62.
45. Makrigiannakis A, Karamouti M, Drakakis P, Loutradis D, Antsaklis A, (2008) Fetomaternal immunotolerance. Am J Reprod Immunol 60: 482-496.
46. Racusen LC, Colvin RB, Solez K, Mihatsch MJ, Halloran PF, et al. (2003) Antibody-mediated rejection criteria- an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 3: 708-714.
47. Takemoto SK, Zeevi A, Feng S, Colvin RB, Jordan S, et al. (2004) National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant 4: 1033-1041.
48. Colvin RB, Smith RN, (2005) Antibody-mediated organ-allograft rejection. Nat Rev Immunol 5: 807-817.
49. Collins AB, Schneeberger EE, Pascual MA, Saidman SL, Williams WW, et al. (1999) Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol 10: 2208-2214.
50. Ionescu DN, Girnita AL, Zeevi A, Duquesnoy R, Pilewski J, et al. (2005) C4d deposition in lung allografts is associated with circulating anti-HLA alloantibody. Transpl Immunol 15: 63-68.
51. Dunn MJ, Crisp SJ, Rose ML, Taylor PM, Yacoub MH, (1992) Anti-endothelial antibodies and coronary artery disease after cardiac transplantation. Lancet 339: 1566-1570.
52. Ball B, Mousson C, Ratignier C, Guignier F, Glotz D, et al. (2000) Antibodies to vascular endothelial cells in chronic rejection of renal allografts. Transplant Proc 32: 353-354.
53. Sumitran-Holgersson S, Wilczek HE, Holgersson J, Soderstrom K, (2002) Identification of the nonclassical HLA molecules, mica, as targets for humoral immunity associated with irreversible rejection of kidney allografts. Transplantation 74: 268-277.
54. Sumitran-Holgersson S, (2008) Relevance of MICA and other non-HLA antibodies in clinical transplantation. Curr Opin Immunol 20: 607-613.
55. Piper KP, McLarnon A, Arrazi J, Horlock C, Ainsworth J, et al. (2007) Functional HY-specific CD8+ T cells are found in a high proportion of women following pregnancy with a male fetus. Biol Reprod 76: 96-101.
56. van Halteren AG, Jankowska-Gan E, Joosten A, Blokland E, Pool J, et al. (2009) Naturally acquired tolerance and sensitization to minor histocompatibility antigens in healthy family members. Blood 114: 2263-2272.
57. Nielsen HS, Mogensen M, Steffensen R, Kruse C, Christiansen OB, (2007) Indications of anti-HY immunity in recurrent placental abruption. J Reprod Immunol 75: 63-69.
58. Melamed N, Yogev Y, Glezerman M, (2010) Fetal gender and pregnancy outcome. J Matern Fetal Neonatal Med 23: 338-344.